Friday, October 30, 2026
BTC $78,401 ▲ 0.77%
Subscribe
Menu
NewsLive WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
MoreDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
LIVE
ADA$0.193up+1.73%ETH$2,237down−0.52%LINK$11.06up+4.30%SOL$97.88up+2.61%BTC$78,401up+0.77%XRP$1.26up+1.80%S&P 5007,720down−0.30%Nasdaq26,185down−1.38%Dow52,343down−0.25%RUT2,859up+1.01%TNX4.99%down−1.11%TYX5.33%down−0.60%FVX4.80%down−1.44%IRX4.00%up+0.08%VIX17.20up+1.71%GOLD$4,012.70down−0.46%SILVER$51.51down−1.66%OIL$103.34up+1.31%DXY101.84down−0.20%NVDA$213.66down−0.80%AAPL$348.91up+1.48%TSLA$403.30down−0.23%META$624.52up+1.96%MSFT$530.14down−0.16%AMZN$243.79down−4.25%GOOGL$283.82down−12.64%Fear & Greed30 — FearADA$0.193up+1.73%ETH$2,237down−0.52%LINK$11.06up+4.30%SOL$97.88up+2.61%BTC$78,401up+0.77%XRP$1.26up+1.80%S&P 5007,720down−0.30%Nasdaq26,185down−1.38%Dow52,343down−0.25%RUT2,859up+1.01%TNX4.99%down−1.11%TYX5.33%down−0.60%FVX4.80%down−1.44%IRX4.00%up+0.08%VIX17.20up+1.71%GOLD$4,012.70down−0.46%SILVER$51.51down−1.66%OIL$103.34up+1.31%DXY101.84down−0.20%NVDA$213.66down−0.80%AAPL$348.91up+1.48%TSLA$403.30down−0.23%META$624.52up+1.96%MSFT$530.14down−0.16%AMZN$243.79down−4.25%GOOGL$283.82down−12.64%Fear & Greed30 — Fear
Tag

stock performance

4 articles

Griffon's Rally Masks Deteriorating Outlook; Analysts Turn Cautious at 16x Forward P/E
U.S. Equities2d ago
Griffon's Rally Masks Deteriorating Outlook; Analysts Turn Cautious at 16x Forward P/E
Griffon shares outperformed the market Tuesday but analyst revisions have turned negative, with full-year revenue expected to fall 27 percent and the stock trading at a significant premium to peers
Waste Management Beats Market as Q3 Earnings Approach Oct. 27
U.S. Equities15d ago
Waste Management Beats Market as Q3 Earnings Approach Oct. 27
WM gained 1.85 percent to $215.75 as investors await third-quarter results expected to show 10 percent EPS growth.
Ginkgo Bioworks (DNA) at $7.06: Why Earnings Collapse Doesn't Tell the Full Story
U.S. Equities43d ago
Ginkgo Bioworks (DNA) at $7.06: Why Earnings Collapse Doesn't Tell the Full Story
DNA shares rose 1 percent as Wall Street braces for a 47 percent revenue miss this quarter—but improving unit economics and autonomous lab milestones suggest the market is pricing in worse
Amazon's $220B AI Bet Mirrors Past Cycle: Losses Led to 118% Stock Rebound
U.S. Equities60d ago
Amazon's $220B AI Bet Mirrors Past Cycle: Losses Led to 118% Stock Rebound
Amazon's record capital spending and AWS GPU commitments follow a pattern: prior investment cycles saw temporary net losses followed by triple-digit stock recoveries.